VEGFA and myelodysplastic syndrome: As shown in Figure 1C, VEGF secretion in patients with MDS (lower- and higher-risk) was higher than that in healthy subjects (P < 0.05 and P < 0.01, respectively) and VEGF secretion was significantly increased in the higher-risk group compared with the lower-risk group (P < 0.05).